Literature DB >> 33052946

Physiological changes in retinal layers thicknesses measured with swept source optical coherence tomography.

Elisa Viladés1,2, Amaya Pérez-Del Palomar2,3, José Cegoñino2,3, Javier Obis1, María Satue1,2, Elvira Orduna1,2, Luis E Pablo1,2, Marta Ciprés1,2, Elena Garcia-Martin1,2.   

Abstract

PURPOSE: To evaluate the physiological changes related with age of all retinal layers thickness measurements in macular and peripapillary areas in healthy eyes.
METHODS: Wide protocol scan (with a field of view of 12x9 cm) from Triton SS-OCT instrument (Topcon Corporation, Japan) was performed 463 heathy eyes from 463 healthy controls. This protocol allows to measure the thickness of the following layers: Retina, Retinal nerve fiber layer (RNFL), Ganglion cell layer (GCL +), GCL++ and choroid. In those layers, mean thickness was compared in four groups of ages: Group 1 (71 healthy subjects aged between 20 and 34 years); Group 2 (65 individuals aged 35-49 years), Group 3 (230 healthy controls aged 50-64 years) and Group 4 (97 healthy subjects aged 65-79 years).
RESULTS: The most significant thinning of all retinal layers occurs particularly in the transition from group 2 to group 3, especially in temporal superior quadrant at RNFL, GCL++ and retinal layers (p≤0.001), and temporal superior, temporal inferior, and temporal half in choroid layer (p<0.001). Curiously group 2 when compared with group 1 presents a significant thickening of RNFL in temporal superior quadrant (p = 0.001), inferior (p<0.001) and temporal (p = 0.001) halves, and also in nasal half in choroid layer (p = 0.001).
CONCLUSIONS: Excepting the RNFL, which shows a thickening until the third decade of life, the rest of the layers seem to have a physiological progressive thinning.

Entities:  

Mesh:

Year:  2020        PMID: 33052946      PMCID: PMC7556480          DOI: 10.1371/journal.pone.0240441

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Currently OCT is widely used in clinical practice and clinical trials accepting their measurements for the evaluation of the response to treatment and the progression of pathologies [1]. Retinal thickness or central macular thickness (CMT) measured with OCT is particularly used, which correlates with pathological changes and response to treatment for a variety of eye diseases [2]. Currently we still accept the thickness of the retina as the space between surfaces detected, but retinal image segmentation is challenging; structures such as vascular structures, macula, and microaneurysms have low contrast with their background. In contrast, other structures have high contrast with background tissues, but they are difficult to distinguish using classical segmentation techniques [1, 3]. Also, recent works have shown that the most commonly used algorithms in daily practice for retinal layer segmentation have a large number of segmentation errors, especially in the case of age-related macular degeneration, great disruptive pathology such as subretinal fluid, intraretinal cysts and retinal detachments that interrupt the structured logical organization of the retinal layers [4, 5]. Currently we can classify the existing segmentation algorithms into two clusters, mathematical modeling and machine learning approaches. Mathematical modeling is based on the previous anatomical, structural and clinical knowledge that is known about the retina. However pure machine learning algorithms for retinal layer segmentation classifies each pixel from an image on how they fall under a particular layer or boundary, that means that boundaries between layers are not linear [2]. Swept-source (SS)-OCT offers potential advantages due to a modified Spectral-domain (SD) and depth resolved technology which includes an improved imaging range, minor sensitivity roll-off with imaging depth, greater detection efficiencies, and an adjustability to longer imaging wavelengths of 1050nm, this allows a greater choroidal penetration and higher speed for image acquisition. The main difference of SS-OCT is that captures the interferences of the backscattered light from the retina thanks to a wavelength sweeping laser light source and a photodiode detector, in contrast to SD-OCT where a line scan camera and a spectrometer record the interferences between a broadband light source. Those improvements on SS-OCT enables higher density raster scan protocols and deeper image penetration, as a result on en-face reconstructions a better visualization of choroidal detail is possible [6]. Swept-source (SS)-OCT with a wavelength of 1,050 nm and 100,000 A-scans/sec has allowed in-depth visualization of the eye from the retina to the sclera even in patients with moderate to severe cataracts, as well as during eye blinking and/or ocular movement. SS-OCT systems have the potential for superior and simultaneous imaging of the retina and choroid because of the longer wavelength, potentially higher detection efficiency, and lower dispersion [7]. Choroidal thinning has been considered more and more important in the last months, because it has been associated with some ophthalmological pathologies such as age-related macular degeneration (AMD), and also in neurodegenerative diseases such as multiple sclerosis [8], Parkinson’s disease [9] or Fibromyalgia [10] and systemic conditions like diabetes mellitus [11] or pathologies with unclear physiopathology such as migraine [12, 13]. Also, age has been found to be negatively correlated with central choroidal thickness and with central choroidal volume [14], choroidal thickness and volume are also negatively statistically significant concerning the refractive error, and axial length measured with low-coherence reflectometry was also found to be negatively correlated with choroidal thickness and volume. On the other hand, sex has not been found to influence choroidal thickness significantly [15]. Imaging of the choroid was dramatically improved with the development of spectral domain optical coherence tomography (SD-OCT) and was further augmented with the advantage of enhanced depth imaging SD-OCT (EDI SD-OCT) by Spaide and colleagues [16]. Even though, standard cross-sectional (Bscan) OCT imaging are still limited, consequently the choroidal assessment is not as detailed as it could be. However, en-face OCT imaging, is able to provide a high-definition three-dimensional and depth-resolved reconstruction of the choroid, revealing choroidal vascular details not easily visible on cross-sectional OCT imaging. Despite this, SD-OCT is the gold standard for clinical assessment and management of chorioretinal disorders, nevertheless the limited depth of penetration (~850nm), could compromise the choroidal assessment although the selection of the enhanced depth imaging (EDI) method [7]. In the absence of automated segmentation software for SS OCT systems, previous investigators have used manual (mostly single-point) measurement techniques using in-built calibers or modification of retinal segmentation lines to evaluate choroidal thickness; given the high anatomic variability of the choroid, these are impractical for clinical use, are highly dependent on location of measurement, and may be subject to further operator effects [17]. Nevertheless, SS-OCT provides objective and automated measurements of the choroid.

Materials and methods

Between 2015 and 2018, 480 healthy withe caucasian patients were recruited for this cross-sectional study. The inclusion criteria were age between 20 and 79 years, refractive error less than ± 5 diopters (D), axial length between 21 and 25 mm, intraocular pressure less than 21mmHg. The exclusion criteria were concomitant ocular disease (such as glaucoma or retinal pathology); systemic pathologies that could impair the visual system; ocular trauma; laser therapy; and pathology affecting the optic nerve and retina (such as glaucoma, optic neuritis, macular degeneration). We excluded eyes with morphometric parameters of optic disc suggestive of subclinical chronic glaucoma (cup to disc ration≥0.5). All participants provided written informed consent to participate in this study. The written informed consent for participants and for the study protocol was approved by the Ethics Committee of Clinic Research in Aragon (CEICA) and by the Ethics Committee of Miguel Servet University Hospital, in Zaragoza, Spain, which specifically approved the study procedures. This study was conducted in accordance with the guidelines established by the principles of the Declaration of Helsinki. Both eyes of each subject were evaluated, but only one of the eyes, randomly selected, was included in the statistical analysis to avoid potential bias by interrelation between eyes of the same subject. In the cases of subjects with exclusion criteria in only one eye, the other eye was selected for the analysis. A total of 13 eyes were excluded because of not enough OCT quality or exclusion criteria detected during the exploration (morphometric parameters of optic disc compatibles with glaucoma, epiretinal membrane or macular hole). Finally, we included 467 eyes (233 males, 234 females), that were classified in four groups in steps of 15 years, as the difference between the youngest and the oldest is 60 years: Group 1 (composed by 71 eyes of 71 healthy subjects aged between 20 and 34 years); Group 2 (composed by 65 eyes of 65 healthy individual aged 35 to 49 years), Group 3 (with 230 eyes from 230 healthy controls aged between 50 and 64 years) and Group 4 (composed by 97 eyes from 97 healthy subjects aged 65–79 years).

OCT evaluation

Retinal measurements were obtained in all subjects using the DRI Triton SS-OCT device (Topcon, Tokyo, Japan). We performed the 3D+5LineCross protocol (12.0*9.0mm + 9.00mm overlap 8), which allows 100.000 A scans/sec. The DRI Triton SS-OCT provides a quality scale in the image to indicate the signal strength. The quality score ranges from 0 (poor quality) to 100 (excellent quality). Only images with a score >55 were analyzed in our study, and poor-quality images prior to data analysis were rejected. We exported data of 5 layers using 3DH_DISC (Disc5.2x5.2-Superpixelgrid-200) and the thickness of the 26x26 grid were analyzed to get mean and standard deviation in the four age groups as shown in Fig 1.
Fig 1

A: Location of 3D+5line cross OCT scans on retina. B: 26*26 grid centered on optic disc, the center area is not shown because the OCT thickness is always zero. C: cross-sectional OCT image and segmentation boundaries.

A: Location of 3D+5line cross OCT scans on retina. B: 26*26 grid centered on optic disc, the center area is not shown because the OCT thickness is always zero. C: cross-sectional OCT image and segmentation boundaries. Using the Data Collector software of the Triton OCT, measurements of full layers and of 5 different layers were obtained (Fig 2): Retinal thickness (from the inner limiting membrane–ILM- to the retinal pigment epithelium boundaries), Retinal nerve fiber layer (RNFL) (between the ILM to the GCL boundaries), Ganglion cell layer (GCL) + (between RNFL to the inner nuclear layer boundaries) and GCL++ (between ILM to the inner nuclear layer boundaries), and choroid (from the Bruch membrane to the choroidal-scleral interface).
Fig 2

Representation of the five layers measured by Triton optical coherence tomography.

Retina (from the inner limiting membrane–ILM- to the retinal pigment epithelium boundaries), Retinal nerve fiber layer (RNFL) (between the ILM to the GCL boundaries), Ganglion cell layer (GCL) + (between RNFL to the inner nuclear layer boundaries), GCL++ (between ILM to the inner nuclear layer boundaries), and choroid (from the Bruch membrane to the choroidal-scleral interface).

Representation of the five layers measured by Triton optical coherence tomography.

Retina (from the inner limiting membrane–ILM- to the retinal pigment epithelium boundaries), Retinal nerve fiber layer (RNFL) (between the ILM to the GCL boundaries), Ganglion cell layer (GCL) + (between RNFL to the inner nuclear layer boundaries), GCL++ (between ILM to the inner nuclear layer boundaries), and choroid (from the Bruch membrane to the choroidal-scleral interface). Automated built-in calibration software, Topcon Advances Boundary Software (TABS) determined the distance between the delimiting lines in retina and choroidal plexus, establishing 7 boundaries and five layers.

Data analysis

Comparison between age groups was performed using analysis of variance (ANOVA) for each thickness measurement for four quadrants and four halves. Post-Hoc analysis was performed to obtain statistical differences in each comparison between the four age groups (Group 1 compared with Group 2; Group 1 compared with Group 3; Group 1 compared with Group 4; Group 2 compared with Group 3; Group 2 compared with Group 4; and Group 3 compared with Group 4). Correction for multiple comparisons was used in all analyses. In order to graphically see the evolution of the thickness of each segmented layer, a numerical method called the finite element method (FEM) was used. Numerical techniques such as the finite element method have been extensively implemented as effective and noninvasive methods to analyze biological tissues, and in particular in ophthalmology [18-20]. The finite element method is a computational tool which allows analysing the stress/strain behaviour of a structure subjected to different loads and boundary conditions. Here, this method has only been used to study the evolution of retinal layers thickness along time and to graphically see the evolution of each of them by a contour plot map. Thus, a finite element mesh using ABAQUS (Abaqus 6.14, Simulia, Rhode Island, USA) mimicking the Triton grid (Disc5.2x5.2-Superpixelgrid-200) was developed. The finite element mesh was constructed using membrane quadrilateral elements and the size of the mesh was 5.2x5.2mm. Afterwards, the thickness of each box of the grid for each group and each layer was introduced. In this way, the evolution of the thickness of each layer can be seen from a spatio-temporal point of view from Group 1 to Group 4.

Results

We analysed a total of 467 eyes from 467 healthy subjects, 71 eyes from 71 individuals between 20–34 years (group 1), 65 eyes from 65 subjects between 35–49 years (group 2), 230 eyes from 230 subjects between 50–64 years (group 3) and 97 eyes from 97 individuals between 65–79 years (group 4). Mean and standard deviation for each layer were represented in Fig 3 for the four age groups.
Fig 3

Representation of mean and standard deviation for each layer measured by Triton optical coherence tomography, for the four age groups.

Group 1 (composed by 71 healthy subjects with age between 20 and 34 years); Group 2 (composed by 65 individuals with 35–49 years), Group 3 (with 230 healthy controls with 50–64 years) and Group 4 (composed by 97 healthy subjects with 65–79 years). On the left column, the mean and standard deviation is shown for each layer and age group. On the right column, the quartiles are plotted to show data dispersion and the presence of outliers.

Representation of mean and standard deviation for each layer measured by Triton optical coherence tomography, for the four age groups.

Group 1 (composed by 71 healthy subjects with age between 20 and 34 years); Group 2 (composed by 65 individuals with 35–49 years), Group 3 (with 230 healthy controls with 50–64 years) and Group 4 (composed by 97 healthy subjects with 65–79 years). On the left column, the mean and standard deviation is shown for each layer and age group. On the right column, the quartiles are plotted to show data dispersion and the presence of outliers. Fig 4 represents the contour map obtained by finite element modeling of the evolution of the thickness of each layer for the different age groups, which shows progressive thinning of all layers with age, especially from 50 years onwards.
Fig 4

Finite element contour map of the evolution of the thickness of each layer measured by Triton optical coherence tomography for the four age groups (20–34 years, 35–49 years, 50–64 years, and 65–80 years).

On the left, the contour bar represents the equivalence between colour and thickness value (in μm) for each layer. Blue zones correspond to thicker areas and red zones correspond to thinner ones. The optic nerve is represented in grey colour. Different scales have been used to represent the thickness value for each layer. It can be seen a progressive thinning of all layers with age, especially from 50 years onwards.

Finite element contour map of the evolution of the thickness of each layer measured by Triton optical coherence tomography for the four age groups (20–34 years, 35–49 years, 50–64 years, and 65–80 years).

On the left, the contour bar represents the equivalence between colour and thickness value (in μm) for each layer. Blue zones correspond to thicker areas and red zones correspond to thinner ones. The optic nerve is represented in grey colour. Different scales have been used to represent the thickness value for each layer. It can be seen a progressive thinning of all layers with age, especially from 50 years onwards. A comparative analysis between age groups were performed for all layers to find thickness differences for four quadrants (temporal superior -TS-; temporal inferior -TI-; nasal superior -NS-; and nasal inferior -NI-) and four halves (superior, inferior, nasal and temporal).

Retinal full layer analysis

There are highly significant differences between groups in our analysis for each quadrant and halves. In the post-hoc analysis, a significant thickening that did not overcome the Bonferroni correction for multiple comparison was found for TI quadrant at group 2 compared with group 1 (p = 0.038) and also at temporal half (p = 0.043). Considerable differences that overcame the Bonferroni correction or multiple comparison were found comparing group 2 vs group 3, in which a thinning trend is visible for TS (p = 0.004), and TI (p = 0.007) quadrants and temporal (p = 0.005) halves. Comparing group 3 vs group 4, significant thinning was found for the four quadrants (p≤0.002), and the four halves (p<0.001). Comparing group 1 vs group 3 we did not find any statistical differences between groups although there is a presumed thinning in group 3. On the other hand, there is an obvious thinning in group 4 compared with group 1 and group 2 for all quadrants and halves (p<0.001).

Retinal nerve fiber layer analysis

Significant differences for all quadrants and halves were found between age groups, except for NS quadrant and nasal half. A significant RNFL thickening that overcame Bonferroni correction was observed at group 2 compared with group 1 in TS quadrant (p = 0.001), inferior half (p<0.001) and temporal half (p = 0.001). Group 3 presents a significant thickening at inferior half (p = 0.002) when compared with group 1, but a significant thinning at TS quadrant (p = 0.001) when compared with group 2. Group 4 presents just a significant thickening at NI quadrant (p = 0.002) compared with group 1, but compared with group 2, it is observed a significant thinning at TS (p<0.001) and TI (p<0.001) quadrants and at superior (p<0.001) and temporal (p<0.001) halves. Same conduct happens when this group is compared with group 3 at TI quadrant (p<0.001) (Table 1).
Table 1

Mean ± standard deviation of four quadrants and halves for age groups in the retinal nerve fiber layer, GCL+ and GCL++, and comparison of thickness between age groups.

Group 1 (20–34 years)Group 2 (35–49 years)Group 3 (50–64 years)Group 4 (65–79 years)P
RNFLTS Quadrant97.10±10.17103.01±10.0597.53±11.7996.36±11.700.001*
TI Quadrant93.16±11.5597.63±9.5797.12±13.6290.49±12.03<0.001*
NS Quadrant88.89±12.2088.70±10.6687.13±14.2285.19±12.040.222
NI Quadrant77.72±10.4482.00±7.5080.94±11.3984.49±15.810.003*
Superior Half92.99±6.3995.87±8.0392.33±10.5590.78±9.940.009
Inferior Half85.44±6.1589.81±6.0889.03±9.1797.49±10.300.007*
Nasal Half83.30±9.3185.35±8.0284.03±11.8284.84±13.160.687
Temporal Half95.13±9.60100.32±7.4197.33±11.8993.42±10.73<0.001*
GCL +TS Quadrant48.87±4.2647.70±5.2947.01±4.6945.10±4.35<0.001*
TI Quadrant53.07±6.2152.36±6.0751.11±5.5149.70±5.630.001*
NS Quadrant40.42±2.9939.27±3.2239.44±4.3138.40±3.820.011
NI Quadrant41.06±3.8439.69±3.6739.13±3.9337.79±5.42<0.001*
Superior Half44.65±3.0543.49±4.343.23±3.7641.75±3.38<0.001*
Inferior Half47.06±4.1446.03±4.1445.15±3.8543.75±4.53<0.001*
Nasal Half40.47±3.1538.48±3.1739.29±3.7238.09±3.87<0.001*
Temporal Half50.97±4.8250.03±5.4449.06±4.7447.40±4.56<0.001*
GCL++TS Quadrant145.98±9.61150.72±11.23144.55±11.72141.47±13.00<0.001*
TI Quadrant146.23±9.25150.01±10.43148.25±13.14140.20±13.29<0.001*
NS Quadrant129.28±13.08128.00±11.89126.49±15.07123.45±13.760.046
NI Quadrant118.78±10.08121.70±8.98120.01±11.65122.10±16.720.263
Superior Half137.63±8.03139.36±10.03135.52±11.74132.46±12.030.001*
Inferior Half132.51±6.73135.85±8.45134.13±10.16131.15±12.680.015
Nasal Half124.03±10.07124.85±9.62123.25±12.53122.78±14.550.709
Temporal Half146.10±8.40150.36±9.29146.40±11.79140.83±12.39<0.001*

The asterisks show significant levels that overcome Bonferroni correction for multiple comparisons, Abbreviations: TS, temporal superior; TI, temporal inferior; NS, nasal superior; NI, nasal inferior.

The asterisks show significant levels that overcome Bonferroni correction for multiple comparisons, Abbreviations: TS, temporal superior; TI, temporal inferior; NS, nasal superior; NI, nasal inferior.

RNFL to inner nuclear layer (GCL+)

GCL+ appears to be significantly thicker in group 2 when comparing with group 4 at TS quadrant (p = 0.001), inferior and temporal halves (p = 0.001), but not compared with groups 1 and 3. Group 3 present a significant thinner GCL+ layer at NI quadrant and inferior half (p<0.001) when compared with group 1, however GCL+ is significantly thicker in this group compared with older population (group 4) at TS quadrant and superior half (p = 0.001). Finally, group 4 exhibits a significant thinning of GCL+ layer for every quadrants and halves (p<0.001) (Table 1).

From inner limiting membrane to inner nuclear layer (GCL++)

Significant differences between groups in the GCL++ layer were found almost in every quadrant and half, except for NI quadrant and nasal half, that apparently are not predictive of changes in this layer (Table 1). Comparing group 3 vs group 1, significant differences were not found, but compared with group 2 significant thinning appears in TS quadrant (p<0.001). On the other hand, group 4 exhibits a thinner GCL++ layer compared with group 1 in TI quadrant (p = 0.001) and superior and temporal halves (p = 0.002). Compared with group 2 thinning gets more significant in TS and TI quadrants (p<0.001), and superior and temporal halves (p<0.001) (Table 1).

Retina (from RNFL to photoreceptors layer)

There are no significant differences when comparing group 1 with group 2, but when comparing with group 3 significant thinning is found at TS and NS quadrants (p = 0.003 and p = 0.001) and superior and nasal halves (p = 0.001 and p = 0.006). Furthermore, when comparing with group 4, significant thinning is found in all quadrants and halves (p<0.001) except for NI quadrant (p = 0.041) (Table 2).
Table 2

Mean ± standard deviation of four quadrants and halves for age groups in the full layers, retina and choroid measurement, and comparison of thickness between age groups.

Group 1 (20–34 years)Group 2 (35–49 years)Group 3 (50–64 years)Group 4 (65–79 years)P
Full layersTS Quadrant498.67±40.41517.52±71.87485.86±79.41458.84±52.42<0.001*
TI Quadrant470.53±50.57493.19±73.98463.30±78.88418.36±47.21<0.001*
NS Quadrant479.50±43.65480.96±68.32465.49±89.01426.43±54.78<0.001*
NI Quadrant436.80±35.97449.07±68.93427.20±82.69389.57±45.18<0.001*
Superior Half489.09±39.43499.24±68.04475.68±83.03442.63±51.55<0.001*
Inferior Half453.67±40.77471.13±69.78445.25±79.36403.97±44.68<0.001*
Nasal Half458.15±38.27465.02±67.74446.35±85.07408.00±47.52<0.001*
Temporal Half484.60±44.81505.35±71.76474.58±78.35438.60±47.09<0.001*
RetinaTS Quadrant300.15±9.62303.03±13.05294.89±14.05290.65±10.68<0.001*
TI Quadrant293.30±10.88298.22±14.59294.78±15.79285.90±13.29<0.001*
NS Quadrant274.31±12.44272.71±14.01266.56±18.82262.47±13.48<0.001*
NI Quadrant259.40±8.85261.13±10.94255.70±16.01255.04±16.130.012
Superior Half287.23±9.01287.87±12.24280.73±15.29276.56±11.16<0.001*
Inferior Half277.85±8.47279.68±12.06275.24±14.68270.47±13.13<0.001*
Nasal Half266.85±9.31266.92±11.81261.13±16.75258.76±14.06<0.001*
Temporal Half298.22±9.38300.63±12.80294.84±14.42288.27±11.30<0.001*
ChoroidTS Quadrant173.28±40.68203.81±77.25168.16±74.45145.42±48.17<0.001*
TI Quadrant149.75±46.90179.46±72.31145.66±73.86109.60±39.44<0.001*
NS Quadrant175.66±43.38193.17±68.84174.84±82.28140.19±47.74<0.001*
NI Quadrant147.86±34.92169.42±68.43147.11±77.33110.51±35.24<0.001*
Superior Half174.47±39.34198.49±71.18146.39±77.27142.81±45.52<0.001*
Inferior Half148.80±38.36174.44±68.99146.39±74.44110.05±35.90<0.001*
Nasal Half161.76±38.04181.30±67.82160.98±78.97125.35±38.98<0.001*
Temporal Half161.52±43.20191.64±73.73156.91±73.27127.51±41.66<0.001*

The asterisks show significant levels that overcome Bonferroni correction for multiple comparisons. Abbreviations: TS, temporal superior; TI, temporal inferior; NS, nasal superior; NI, nasal inferior.

The asterisks show significant levels that overcome Bonferroni correction for multiple comparisons. Abbreviations: TS, temporal superior; TI, temporal inferior; NS, nasal superior; NI, nasal inferior. By contrast comparing group 2 with group 3, there seems to be a significant thinning at TS (p<0.001), NS (p = 0.013) and NI (p = 0.009) quadrants and all halves (p<0.001, p = 0.024, p = 0.008, p = 0.003), but when comparing with group 4 significant thinning occurs in all quadrants (p<0.001, p<0.001, p<0.001 and p = 0.008) and all halves (p<0.001). Finally, when comparing group 3 with group 4 significant thinning is found at TS (p = 0.008) and TI (p<0.001) quadrants and superior (p = 0.016) and temporal (p<0.001) halves.

Choroid analysis

Choroid howed significant differences between age groups for all quadrants and halves (Table 2). At second age group (35 to 49 years) it seems to exist a choroidal thickening at superior half (p = 0.001) when compared with group 1. By contrast, group 3 presents a thinner choroidal layer compared with previous groups, but this thinning is just significant when compared with group 2 for TS and TI quadrants, and for temporal half (p<0.001). The thinnest choroidal values can be seen for group 4, which is significant when comparing with group 1, 2 of 3 for every parameter analyzed (p<0.001). Except the GCL+ with a linear thinning ratio of -0.050 μm/year, the tendency in the other layers differs. A thickening ratio of 0.476 μm/year for the full layers complex, 0.010 μm/year for the retina, 0.856 μm/year for the choroid, 0.125 μm/years for the RNFL and 0.087 μm/years for the GCL++ is observed until de third decade of life. Subsequently a thinning ratio of -1.406 μm/year for the full layers complex, -0.058 μm/year for the retina, -1.364 μm/year for the choroid, -0.084 μm/years for the RNFL and -0.131 μm/years for the GCL++ is observed from de third decade of life.

Discussion

Previous histopathological studies of the choroid have shown that choroidal thickness decreases with age; this finding has been confirmed by posterior in-vivo studies [7, 14, 17, 21]. Choroidal thinning on OCT has been associated with ophthalmological conditions such as age-related macular degeneration, age-related choroidal atrophy, axial length, or systemic conditions such as diabetes, Alzheimer’s disease, cognitive impairment, vascular diseases or obesity [11, 21, 22]. In addition, the loss of vascular perfusion related to age has been described in previous studies performed with OCT-Angiography [23], even this alteration of blood flow could be observed by magnetic resonance [24]. Furthermore, a significant reduction of retrobulbar circulation related to age has been found in Doppler studies, this reduction could be also related with the increased prevalence of cardiovascular risks related with age such as hypertension, diabetes, lipid disorders and sedentary lifestyle [25-28]. Traditionally, the age of 40 years has been established as the age of onset of the classic ophthalmological alterations, although other pathologies such as macular alterations are more common beyond 50 years, so these changes in the choroid can be a predictive factor of future clinical alterations [7, 29, 30]. In our study, we have seen that global retinal tendency is toward thickening in the third decade of life (group 2) and towards thinning after the fourth decade (group 3). Regarding the choroid, the same pattern was seen and also for the rest of layers, except at GCL+ layer, where there is a continuous thinning from group 1 to group 4. These results are consistent with those of Hanumunthadu et al. 2018, their age-stratified analysis suggested that choroidal thickness was smaller in children and younger adult population, and it appeared to decrease again in older adults [21]. In contrast with published studies, our analysis has focused on a division by quadrants and halves in the peripapillary area. We observed that superior half and quadrants are thicker than their inferior homologous, however, it seems that there is no difference when comparing nasal and temporal orientation. As we have seen previously, group 1 seems to have a very similar choroidal thickness to group 3 in practically all the quadrants and halves, except in the superior half, where apparently the thickness of the choroid is greater in this group. Comparing the thinning of the total retina and the one produced specifically in the choroid, we can see that it is in group 4 where the thinning of this last layer is more pronounced, especially in the inferior half of the retina. Same thing happens for groups 1 and 2, but not in 3, where thinning is symmetric when comparing the superior quadrants and halves with the inferior ones and the nasal quadrants and halves with the temporal ones. The potential clinical application of our findings is to know which thickness values in each layer should be considered pathological. This study may be the base to build a normative database that allows health personnel to improve the interpretation of retinal measurements, even with a color scale similar to that one used by most OCT devices (red color means pathological thinning, yellow color indicated slight thinning, green color means normal, blue indicates slight thickening and purple means abnormal thickening); this helps to determine which layers are out of normal limits in each range of age. This is an important limitation of the Triton current software because we can visualize numerous measurements of all retinal layers, but ophthalmologists do not know if these values are normal for the age of each subject or patient. Our findings suggest that there is a progressive and physiological thinning of all retinal layers from the third decade of life. In any case, it would be useful to extend this study further with a larger population of ordinary individuals across a range of different ethnicities and from longer geographic areas, to clarify the physio-pathological mechanisms that affect retinal layers. (SAV) Click here for additional data file. 1 Jun 2020 PONE-D-20-02557 Physiological changes in retinal layers thicknesses measured with swept source optical coherence tomography. PLOS ONE Dear Dr. Garcia-Martin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Reviewers have provided constructive criticisms that need to be addressed satisfactorily during revision. The reviewers also opin that novel information of intraretinal layers over aging has not been provided in the manuscript. Please submit your revised manuscript by Jul 16 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Sanjoy Bhattacharya Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for including your ethics statement:  "All subjects gave detailed consent to participate in this study, which was conducted in accordance with the guidelines determined by the Ethics Committee of the Miguel Servet Hospital and the principles of the Declaration of Helsinki." Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 3. Please include a copy of Table 4 which you refer to in your text on page 9. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors collects SS-OCT scans and analyzed the results from a large cohort which is interesting. However, the paper did not provide novel information of intraretinal layers over aging. 1. the authors did not present the results of all intraretinal layers such as INL, OPL, ONL and PR. However, some selected layers and their combinations are presented and the majority of these presented layers are not commonly used in clinic. For example, we all use RNFL and GCIPL in addition to the retinal thickness. 2. Although the SS-OCT scans a large area which may be better than the 6 x 6 mm scan area commonly used in clinic and research. On the other hand, the large area may prevent further comparison if the normality data is not available. 3. The authors did not provide the details of scan settings such scan lines and area, and did not provide the details of 3D segmentation methods. 4. The authors will need to provide a cross-sectional OCT image and show the segmentation boundaries and 3D map. 5. The age grouping is highly arbitrary and the authors need to provide the justification of the cut-off setting. It would be a good approach to use scatterplot to show the trend. 5. The changes of intraretinal layers have been well documented and this manuscript did not report new findings, nor new database (since the device is not commonly used in the clinic). 6. The numbers appear to be wrong since the retinal thickness cannot be about 500,00 microns. It should be about 500.00 microns. Similarily, P should be < 0.001, instead of P < 0,001. 7. The simple conclusion is the thinning of retinal layer, which is well documented. However, the authors did not provide the thinning rate. 8. There are missing data in the center as shown in Fig. 3. Why is the center area trimmed and shown black. Did the center of the fovea was aligned from each map? Or this is just a numerical demonstration. Reviewer #2: a thickening until de third decade of live,: I will change it to third decade of life not live. line 75: possible not posible line 84: systemic conditions like diabetes mellitus 11 or migraine: why considering migraine systemic condition? Line 91: advent: I will write it advantage instead line 93: Even so,: should be even though did U mention in this article the race of the patients, like white, AA or east Asian...etc, I mean U did not mention the ethnicity of your study population ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Feras Mohder [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 6 Jul 2020 We thank reviewers and editor for providing us with very pertinent and helpful comments Submitted filename: Responses to reviewers.docx Click here for additional data file. 28 Sep 2020 Physiological changes in retinal layers thicknesses measured with swept source optical coherence tomography. PONE-D-20-02557R1 Dear Dr. Garcia-Martin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sanjoy Bhattacharya Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This reviewer has no further comments. All comments in the previous review have been addressed and changes have been made. Reviewer #2: What are the reasons that the groups in your study are not in equal numbers? in line 38: u wrote double in , you may delete one of them. in line 41: U can replace de with the. in line 70: " from retina thanks to a wavelength": I really did not understand what do U mean in this line? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Feras Mohder 5 Oct 2020 PONE-D-20-02557R1 Physiological changes in retinal layers thicknesses measured with swept source optical coherence tomography. Dear Dr. Garcia-Martin: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sanjoy Bhattacharya Academic Editor PLOS ONE
  30 in total

1.  Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments.

Authors:  Sebastian M Waldstein; Bianca S Gerendas; Alessio Montuoro; Christian Simader; Ursula Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2015-01-06       Impact factor: 4.638

2.  Finite Element Biomechanics of Optic Nerve Sheath Traction in Adduction.

Authors:  Andrew Shin; Lawrence Yoo; Joseph Park; Joseph L Demer
Journal:  J Biomech Eng       Date:  2017-10-01       Impact factor: 2.097

3.  Comparison of choroidal vessel thickness in children and adult eyes by enhanced-depth imaging optical coherence tomography imaging.

Authors:  Daren Hanumunthadu; Jorge Ruiz-Medrano; Sunila Dumpala; Ayesha Jabeen; Asiya Jabeen; Abhilash Goud; José M Ruiz-Moreno; Jay Chhablani
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

4.  Embolic central retinal artery occlusion detected by orbital color Doppler imaging.

Authors:  Rod Foroozan; Peter J Savino; Robert C Sergott
Journal:  Ophthalmology       Date:  2002-04       Impact factor: 12.079

5.  Retinal nerve fiber layer, ganglion cell complex, and choroidal thicknesses in migraine.

Authors:  Hatice Nur Colak; Feride Aylin Kantarcı; Mehmet Gurkan Tatar; Mehmet Eryilmaz; Hasim Uslu; Hasan Goker; Aydin Yildirim; Bulent Gurler
Journal:  Arq Bras Oftalmol       Date:  2016-04       Impact factor: 0.872

6.  Characterization of Choroidal Layers in Normal Aging Eyes Using Enface Swept-Source Optical Coherence Tomography.

Authors:  Mehreen Adhi; Daniela Ferrara; Robert F Mullins; Caroline R Baumal; Kathrin J Mohler; Martin F Kraus; Jonathan Liu; Emmerson Badaro; Tarek Alasil; Joachim Hornegger; James G Fujimoto; Jay S Duker; Nadia K Waheed
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

7.  Open-source algorithm for automatic choroid segmentation of OCT volume reconstructions.

Authors:  Javier Mazzaferri; Luke Beaton; Gisèle Hounye; Diane N Sayah; Santiago Costantino
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

8.  Correlation of Aging and Segmental Choroidal Thickness Measurement using Swept Source Optical Coherence Tomography in Healthy Eyes.

Authors:  Yu Wakatsuki; Ari Shinojima; Akiyuki Kawamura; Mitsuko Yuzawa
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

9.  Choroidal thickness in patients with fibromyalgia and correlation with disease severity.

Authors:  Mahmut Oguz Ulusoy; Ali Kal; Selen Işik-Ulusoy; Öznur Kal
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

10.  Choroidal thickness in normal Indian subjects using Swept source optical coherence tomography.

Authors:  Zeeshan Akhtar; Pukhraj Rishi; Ramasubramanian Srikanth; Ekta Rishi; Muna Bhende; Rajiv Raman
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

View more
  2 in total

1.  Comparison of Machine Learning Methods Using Spectralis OCT for Diagnosis and Disability Progression Prognosis in Multiple Sclerosis.

Authors:  Alberto Montolío; José Cegoñino; Elena Garcia-Martin; Amaya Pérez Del Palomar
Journal:  Ann Biomed Eng       Date:  2022-02-26       Impact factor: 3.934

2.  Retinal and Choroidal Thinning-A Predictor of Coronary Artery Occlusion?

Authors:  Indrė Matulevičiūtė; Agnė Sidaraitė; Vacis Tatarūnas; Audronė Veikutienė; Olivija Dobilienė; Dalia Žaliūnienė
Journal:  Diagnostics (Basel)       Date:  2022-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.